How can physicians bring cryobiopsy and cryoextraction procedures to more patients with lung disease? That's the challenge Olympus and Endocision are helping address by combining Olympus' expertise in endoscopic imaging with Endocision's innovative cryotechnology. Designed for portability and use across multiple care settings, this technology can help expand access to important diagnostic and therapeutic bronchoscopic procedures in bronchoscopy suites, ICUs, operating rooms and emergency departments. Learn more: http://spkl.io/604673y4p
概要
Olympus is passionate about creating customer-driven solutions for the medical, life sciences, and industrial equipment industries. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 35,000 employees worldwide in nearly 40 countries and regions.
- ウェブサイト
-
https://www.olympus-global.com/
オリンパス株式会社の外部リンク
- 業種
- 医療機器製造業
- 会社規模
- 社員 10,001名以上
- 本社
- Shinjuku-ku、Tokyo
- 種類
- 上場企業
- 創立
- 1919
場所
-
プライマリ
道順を表示
Nishi-shinjuku 2-3-1 Shinjuku Monolith
Shinjuku-ku、Tokyo、JP
オリンパス株式会社の社員
アップデート
-
Our financial results for FY2027 Q1 are now available, showing a solid start for the fiscal year. We delivered overall year-on-year revenue growth with continued momentum in Gastrointestinal Solutions and strong performance in the core franchises of Surgical and Interventional Solutions, Urology and Respiratory. Behind these results is our continued focus on advancing technologies that help healthcare professionals deliver better care and improve patients’ quality of life. Our Purpose of “Making people’s lives healthier, safer, and more fulfilling” will guide us for the rest of the year and beyond. ▶️Click through for other highlights: http://spkl.io/60017M1WJ
-
-
#オリンパス #28卒向け オリンパスグループ5社の仕事と働く人が分かる!合同説明会 予約受付開始! (7/27~) オリンパス株式会社および国内グループ会社を知る説明会を開催いたします。 本イベントでは、オリンパス株式会社と国内グループ4社について、一度に知ることができます。各社の事業や役割、職種について理解を深められるだけでなく、実際に働く先輩社員との座談会も実施予定です。 7/27(月)より予約を受け付けております! 入社理由や仕事内容、働き方など、採用サイトだけでは分からないリアルな話を聞くことができます。 業界研究・企業研究を進めたい方はもちろん、「自分に合う仕事を探したい」「働くイメージを具体化したい」という方にもおすすめです。 詳細や予約方法はマイページでご案内します。まずは、マイページへご登録ください。 ▶ http://spkl.io/60487K34Q ■日程 ①8月24日(月)13:00~15:15 ②8月26日(水)13:00~15:15 ※※両日とも 同じ内容です。ご都合の良い日程でご参加ください。 ※終了時間は予定です。当日の状況によって前後する可能性があります。 ■開催形式 オンライン(Zoom) ※本イベントは、 ①事前視聴動画 ②オンライン説明会 の2ステップで実施します。
-
-
Resharing this important perspective from our Chief Medical Officer, John de Csepel, MD: expanding colorectal cancer (CRC) screening options is progress but ensuring follow‑up colonoscopy is critical to saving lives.
Recent updates to the American Cancer Society’s colorectal cancer (CRC) screening guidelines represent meaningful progress in expanding access to early detection: https://lnkd.in/gK3fpmCc By including additional blood- and stool-based screening options, these guidelines have the potential to lower barriers and bring more people into the colorectal cancer screening pathway—an important step forward in closing the screening gap. But it’s critical to recognize an equally important truth: for many patients, these non-invasive options are just the first step. An abnormal result from a blood- or stool-based test should be followed by a diagnostic colonoscopy to confirm findings and enable timely intervention. Without that follow-through, we risk missing the opportunity to detect and treat colorectal cancer when outcomes are most favorable. Colorectal cancer is one of the most preventable and treatable cancers when detected early. That’s why our focus must remain on the full continuum of care: ✅ Expanding access to screening ✅ Increasing participation ✅ Ensuring timely follow-up As a medical community, we have an opportunity and a responsibility to strengthen each step of this pathway and help more patients benefit from early detection. Olympus Corporation
-
-
Thank you to Emory University - Goizueta Business School for your recent visit to Olympus headquarters! We were happy to connect with the upcoming generation for day focused on innovation, leadership, and more.
Emory University EMBA Students Visit Olympus Tokyo HQ & R&D Center It was a privilege to welcome Professor Charlie Goetz and the EMBA cohort from Emory University - Goizueta Business School to Olympus Corporation HQ and R&D center at Ishikawa (Tokyo). Moments like this remind me how energizing it is to connect with curious minds and share Olympus’ journey—from our roots in optics & cameras, and innovations in Endoscopy to our future in AI‑enabled healthcare. From exploring our 100+ year old heritage in the Olympus Museum to an engaging fireside chat on human‑centered design, cybersecurity, supply‑chain resilience, and the future of healthcare, the conversations were both thoughtful and inspiring. We wrapped up with a dynamic Q&A on innovation and leadership—an exchange that left me optimistic about the next generation shaping the healthcare ecosystem. Olympus Corporation Charlie Goetz #Leadership #HealthcareInnovation #AIinHealthcare #MedTech #RAndD
-
-
What will define the future of GI care? After #ESGEDays2026, the answer is clear: how we connect advanced imaging, AI, and clinical workflow. 🔍 At our booth, clinicians experienced how the EVIS X1™ endoscopy system, combined with the OLYSENSE™ platform, is helping make subtle lesions visible, supporting early detection of colorectal cancer. 🔬 Across scientific sessions, including our symposium with leading experts Prof. Dr. Stefan Seewald, Prof. Dr. Alanna Ebigbo, Prof. Dr. Michał Kamiński, and PD Dr. med. Torsten Beyna, we explored how AI-assisted detection is moving from promise to practical adoption, raising important questions about standardization, training, and clinical integration. 💡Our biggest takeaway? It’s no longer just about better images; innovation only delivers value when it fits seamlessly into the end-to-end workflow, from detection to decision-making to therapy.
-
At Olympus, our commitment to putting patients first includes working with cancer societies worldwide. We recently partnered with the Korean Cancer Society to host the 'Going-on Walk' during Cancer Surivors Week in Korea, bringing together cancer survivors, their families, and Olympus employees to connect and give back. Key highlights from the event include: 🔹100+ Participants: Cancer survivors, families, and Olympus Korea volunteers 🔹382 kg of Marine Waste Collected: Cleared the coastline at Masian Beach in Yeongjongdo ahead of World Environment Day 🔹Meaningful Connections: Participants shared powerful stories of recovery and mutual support 🔹Creative Outlets: Activities included upcycling workshops using sea glass We extend our heartfelt gratitude to everyone who participated in this event and who continue to help us create a more supportive world for cancer survivors.💙
-
-
For high volume, high impact GI interventions like colonoscopy and ESD procedures, Olympus is bringing robotic innovation closer to everyday clinical practice. In this MedTech Dive interview, Keith Boettiger, Executive Officer & Head of Olympus’ Gastrointestinal Solutions Division, shares how we’re advancing a two-pronged endoluminal robotics strategy: ✅ Long-term platform innovation via Swan EndoSurgical ✅ Near-term solution through a partnership with EndoRobotics The goal? Expand access to complex procedures, reduce the steep learning curve for clinicians, and ultimately shift more GI care to minimally invasive approaches; a meaningful step toward improving patient outcomes and expanding access to care. 🔗Full article: http://spkl.io/60497DF6c
-
Endoscopy on Air's global event is coming up next week! Experience live cases and physician expert lectures. Register today to participate: http://spkl.io/604876wP4
Endoscopy On Air brings you a message from Olympus Corporation: Maximize control. Minimize migration. In partnership with W. L. Gore & Associates, Inc., Olympus brings a fully covered self-expanding metal stent to healthcare providers caring for patients with malignant biliary obstruction, the GORE® VIABIL® Biliary Endoprosthesis. This innovative stent addresses key challenges in biliary stenting and is designed to restore the bile flow. Participate in Endoscopy on Air's global event on June 5 to hear more about this innovative biliary endoprosthesis! Register here: https://lnkd.in/dVryDzj6
-
-
Make sure to register to attend Endoscopy on Air's upcoming global event: http://spkl.io/604076wOe
Endoscopy On Air brings you a message from Olympus Corporation: Twice the expertise, twice the confidence for you and your patients. Through a partnership with Canon, Olympus brings the future of EUS into full focus with the Aplio i800 EUS premium ultrasound system. The Aplio i800 EUS system aids in the diagnosis of a wide range of liver and pancreatic diseases and partners seamlessly with your existing workflows. Join us at Endoscopy on Air's global event to dive into the details! Register here: https://lnkd.in/dVryDzj6
-